Tetrasul
Highest phase reached
Phase 2
Drug type
Small molecule
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Small molecule
- Drug name
- Tetrasul
- Molecular weight
- 324.06
- Structure (SMILES)
- Clc1ccc(Sc2cc(Cl)c(Cl)cc2Cl)cc1
- 2 4 4 5 tetrachlorodiphenyl sulfide
- 2,4,4',5-TETRACHLORODIPHENYL SULFIDE
- animert
- Animert
- p chlorophenyl 2 4 5 trichlorophenyl sulfide
- P-CHLOROPHENYL 2,4,5-TRICHLOROPHENYL SULFIDE
- sulfide p chlorophenyl 2 4 5 trichlorophenyl
- SULFIDE, P-CHLOROPHENYL 2,4,5-TRICHLOROPHENYL
- tetrasul
- Tetrasul
- TETRASUL [ISO]
- tetrasul iso
- v 101
- V-101
- CAS registry numbers
- 2227-13-6
- ChEMBL ID
- CHEMBL1365576
- InChIKey
- QUWSDLYBOVGOCW-UHFFFAOYSA-N
- PubChem compound IDs
- 16685
- FDA ingredient codes (UNII)
- BEO7JP5U0R
- First in class
- No
- Orphan designation
- No
Investigated indications
- Condition
- Rosacea
- Highest recorded phase
- 2
- Condition identifier
- EFO:1000760
- Subject identifier
- D012393
- Condition identifier
- EFO_1000760
- Highest recorded phase
- 2
- Condition identifier
- HP_0010783
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0006604
- Highest recorded phase
- 2
Trial references
- NCT01186068
- Hydrogen bond acceptors
- 1
- Hydrogen bond donors
- 0
- Polar surface area
- 0
- Calculated partition coefficient (ALogP)
- 6.45
- Calculated partition coefficient (XLogP)
- 6.5
- Prodrug
- No
- Chirality
- Achiral
- Inorganic
- No
- Rule-of-five violations
- 1
- Rotatable bonds
- 2
- Heavy atoms
- 17
- Molecular formula
- C12H6Cl4S
- Monoisotopic mass
- 321.894432
- Natural product
- Yes
- Recorded assays
- 1,227
- Active assays
- 32
- Confirmatory
- Other
- Summary
Related records
Trials (2)
- A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination
- Dose Response Study of Patients With Erythematous Rosacea
In development for (1)
- Rosacea Phase 2